yondelis
specialised therapeutics limited - trabectedin 0.25mg - powder for infusion - 0.25 mg - active: trabectedin 0.25mg excipient: monobasic potassium phosphate phosphoric acid potassium hydroxide sucrose - yondelis is indicated for the treatment of patients with unresectable or metastatic liposarcoma or leiomyosarcoma who received a prior anthracycline-containing regimen.
trabectedin sun 0,25 mg pulver für ein konzentrat zur herstellung einer infusionslösung
trabectedin sun 1 mg pulver für ein konzentrat zur herstellung einer infusionslösung
trabectedin-ratiopharm 1 mg pulver für ein konzentrat zur herstellung einer infusionslösung
yondelis 1mg for injection
zuellig pharma sdn bhd - trabectedin -
trabectedin ever pharma 1 mg pulver für ein konzentrat zur herstellung einer infusionslösung
yondelis powder for soln. for injection 1 mg/vial
wael pharmacy - trabectedin - powder for soln. for injection - 1
yondelis 1 mg powder for concentrate for solution for infusion powder, for solution
janssen pharmaceutica n.v., switzerland - trabectedin - powder, for solution - 1 mg
yondelis 1 mg powder for concentrate for solution for infusion
pharma mar s.a, spain - trabectedin - powder for concentrate for solution for infusion - 1 mg
yondelis i.v. infusion 0.25mg (ヨンデリス点滴静注用0.25mg)
taiho pharmaceutical co.,ltd. - trabectedin - injection